U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07178652) titled 'Preeclampsia and Defective Placentation in Oocyte Donation: Importance of HLA-C and KIR' on Sept. 02.
Brief Summary: The IMMUN-OR study aims to study HLA-C/KIR combinations when looking at the risk of development of preeclampsia (PE) in pregnancies after oocyte donation. With the use of oocyte donation currently on the rise, the importance of identifying risk factors for the higher frequency of PE development is clear. Certain HLA-C/KIR combinations have already been linked to higher risk of obstetric complications. This study will look at these combinations within the specific situation of oocyte donation. This will further invest...